ADVANCED SOLID CANCER
Clinical trials for ADVANCED SOLID CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SOLID CANCER trials appear
Sign up with your email to follow new studies for ADVANCED SOLID CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced cancer patients as First-in-Human drug trial begins
Disease control Recruiting nowThis is the first time a new drug called SIM0609 is being tested in people. The main goals are to find a safe dose and see how the body processes it. The study will also look for early signs that the drug might help shrink tumors in adults with advanced solid cancers who have no …
Matched conditions: ADVANCED SOLID CANCER
Phase: PHASE1 • Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
New drug targets 'Undruggable' cancer mutation in first human trial
Disease control Recruiting nowThis is the first study to test a new drug called ARV-806 in people with advanced solid tumors that have a specific KRAS G12D mutation. The main goals are to find a safe dose and see how the body processes the drug, while also looking for early signs that it can shrink tumors. Th…
Matched conditions: ADVANCED SOLID CANCER
Phase: PHASE1, PHASE2 • Sponsor: Arvinas Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New cancer drug enters human testing for advanced tumors
Disease control Recruiting nowThis is the first human study of a new experimental drug called APX-343A for people with advanced solid tumors that have spread. The main goal is to find a safe dose and see how the body handles the drug, both by itself and when combined with an existing immunotherapy (pembrolizu…
Matched conditions: ADVANCED SOLID CANCER
Phase: PHASE1 • Sponsor: Aptabio Therapeutics, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New cancer drug enters human testing for advanced tumors
Disease control Recruiting nowThis early-stage study is testing a new drug called MHB046C in people with advanced solid tumors that haven't responded to standard treatments. Researchers will first find the safest dose, then see if the drug helps shrink tumors. The study involves about 200 participants and foc…
Matched conditions: ADVANCED SOLID CANCER
Phase: PHASE1, PHASE2 • Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd • Aim: Disease control
Last updated Mar 06, 2026 15:38 UTC